EXAGEN INC. Retained Earnings
EXAGEN INC. (XGN) had Retained Earnings of -$321.44 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-04
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$321.44M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$318.25M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$314.28M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$309.61M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$321.44M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | -$318.25M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | -$314.28M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | -$309.61M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | -$302.52M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | -$298.08M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | -$294.33M 10-K · filed 2026-03-10 | |
| 2024-09-30 | -$290.57M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$285.54M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | -$282.58M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$279.22M 10-K · filed 2025-03-11 | |
| 2023-09-30 | -$273.64M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$268.23M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | -$263.21M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$255.53M 10-K · filed 2024-03-18 | |
| 2022-09-30 | -$241.17M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | -$233.08M 10-Q/A · filed 2022-11-21 | -$231.72M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$218.41M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | -$208.14M 10-K · filed 2023-03-20 | |
| 2021-09-30 | -$201.09M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | -$193.91M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | -$187.50M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | -$181.29M 10-K · filed 2022-03-22 | |
| 2020-09-30 | -$177.84M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | -$173.53M 10-Q · filed 2020-07-28 | |
| 2020-03-31 | -$170.16M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$164.60M 10-K · filed 2021-03-16 | |
| 2019-09-30 | -$161.19M 10-Q · filed 2019-11-12 | |
| 2018-12-31 | -$152.56M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |